dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Carvajal, Silvia |
dc.contributor.author | Perramón, Meritxell |
dc.contributor.author | Oró, Denise |
dc.contributor.author | Casals, Eudald |
dc.contributor.author | Fernández-Varo, Guillermo |
dc.contributor.author | Casals, Gregori |
dc.contributor.author | Franco Puntes, Victor |
dc.date.accessioned | 2020-03-17T09:25:37Z |
dc.date.available | 2020-03-17T09:25:37Z |
dc.date.issued | 2019-09-06 |
dc.identifier.citation | Carvajal S, Perramón M, Oró D, Casals E, Fernández-Varo G, Casals G, et al. Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease. Sci Rep. 2019 Sep 6;9:12848. |
dc.identifier.issn | 2045-2322 |
dc.identifier.uri | https://hdl.handle.net/11351/4734 |
dc.description | Nanopartículas de óxido de cerio; Enfermedad del hígado graso no alcohólico; Agente antioxidante |
dc.language.iso | eng |
dc.publisher | Nature Publishing Group |
dc.relation.ispartofseries | Scientific Reports;9 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Esteatosi hepàtica |
dc.subject | Nanopartícules |
dc.subject | Antioxidants |
dc.subject.mesh | Metal Nanoparticles |
dc.subject.mesh | Non-alcoholic Fatty Liver Disease |
dc.subject.mesh | Free Radical Scavengers |
dc.title | Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41598-019-49262-2 |
dc.subject.decs | nanopartículas metálicas |
dc.subject.decs | esteatosis hepática no alcohólica |
dc.subject.decs | depuradores de radicales libres |
dc.relation.publishversion | https://www.nature.com/articles/s41598-019-49262-2 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Carvajal S, Perramón M, Oró D] Biochemistry and Molecular Genetics Service, Hospital Clínic Universitari, IDIBAPS, Barcelona, Spain. Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas (CIBEREHD), Madrid, Spain. [Casals E] School of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China. [Fernández-Varo G] Biochemistry and Molecular Genetics Service, Hospital Clínic Universitari, IDIBAPS, Barcelona, Spain. Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas (CIBEREHD), Madrid, Spain. Department of Biomedicine, University of Barcelona, Barcelona, Spain. [Casals G] Biochemistry and Molecular Genetics Service, Hospital Clínic Universitari, IDIBAPS, Barcelona, Spain. Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas (CIBEREHD), Madrid, Spain. Working group for the biochemical assessment of hepatic disease-SEQCML, Barcelona, Spain. [Puntes V] Institut Català de Recerca i Estudis Avançats, (ICREA), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Institut Català de Nanociència i Nanotecnologia (ICN2), Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 31492960 |
dc.identifier.wos | 000484656700036 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |